Eytan Aharon Ben-ami

Dr. Eytan Aharon Ben-Ami is a medical oncologist at Sheba Medical Center. He founded the Sheba Clinical Research Organization to move early-phase cancer trials forward. He treats aggressive sarcomas and primary bone tumors.

Clinical Specialization and Rare Cancer Treatment

Dr. Ben-Ami treats malignancies of the soft tissue and bones. He helps patients with rare subtypes like liposarcoma and leiomyosarcoma. The doctor also treats primary bone tumors, including osteosarcoma and chondrosarcoma. He works with both pediatric and adult teams for these cases.

His approach uses targeted therapy and immunotherapy. These methods help him create treatment plans for rare cancers. Dr. Ben-Ami also applies CAR NK and Natural Killer cell therapies. These options provide alternatives for patients with diseases that are difficult to treat.

Leadership in Clinical Innovation

As Head of the Early-Phase Clinical Trials Unit, he leads Phase I studies. These trials give patients access to next-generation therapies. He also develops programs to improve care delivery. This work includes pilot projects for immunotherapy delivery in clinical settings.

Professional Experience

• Senior Physician, Sarcoma and Bone Oncology Service, Sheba Medical Center
• Head of Oncology Division, Sheba Medical Center
• Head of Early-Phase Clinical Trials Unit, Sheba Medical Center
• Founder, Sheba Clinical Research Organization (CRO)
• Academic Affiliate, Tel Aviv University

Education and Advanced Training

• Medical Degree (MD)
• Fellowship in Sarcoma and Bone Oncology, Dana-Farber Cancer Institute / Harvard Cancer Center

Scientific Research and Publications

Dr. Ben-Ami has authored over 40 scientific publications. His research focuses on the molecular and viral mechanisms of rare tumors. He also investigates methods for early sarcoma detection and monitoring. This scientific work helps develop oncology treatments for aggressive cancers.